The specific OMdPs in bEVs, SDR, ATPD, trxA, and DnaK were found to have the ability to dock with the neurotoxic AD peptide Aβ42 (Fig. 6, E, G, I, and K). This evidence concerns the gene CAVIN2 and Alzheimer disease.